Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
Conditions: Fibrolamellar Hepatocellular Carcinoma; Hepatocellular Carcinoma (Fibrolamellar Variant); Hepatocellular Carcinoma
Interventions: Procedure: living related donor partial liver transplantation; Radiation: Total body irradiation; Procedure: Bone marrow transplant from same donor; Drug: Cyclophosphamide; Drug: Mesna; Drug: Filgrastim; Drug: Tacrolimus; Drug: mycophenolate mofetil; Drug: Prednisone; Drug: Antithymocyte globulin; Drug: fludarabine
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Fibrolamellar Cancer Foundation
Recruiting - verified May 2016
Interventions: Procedure: living related donor partial liver transplantation; Radiation: Total body irradiation; Procedure: Bone marrow transplant from same donor; Drug: Cyclophosphamide; Drug: Mesna; Drug: Filgrastim; Drug: Tacrolimus; Drug: mycophenolate mofetil; Drug: Prednisone; Drug: Antithymocyte globulin; Drug: fludarabine
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Fibrolamellar Cancer Foundation
Recruiting - verified May 2016
News Type: